Evaluation of the Expression Pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 Serotypes With Different Promoters in the Mouse Visual Cortex

被引:36
|
作者
Scheyltjens, Isabelle [1 ]
Laramee, Marie-Eve [1 ]
Van den Haute, Chris [2 ,3 ]
Gijsbers, Rik [3 ,4 ]
Debyser, Zeger [4 ]
Baekelandt, Veerle [2 ]
Vreysen, Samme [1 ]
Arckens, Lutgarde [1 ]
机构
[1] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, Dept Biol, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, B-3000 Leuven, Belgium
[3] Katholieke Univ Leuven, Leuven Viral Vector Core, B-3000 Leuven, Belgium
[4] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium
关键词
viral vector; GABA; CMV; CaMKII alpha; connectivity; optogenetic; ADENOASSOCIATED VIRUS TYPE-2; NONHUMAN PRIMATE BRAIN; CENTRAL-NERVOUS-SYSTEM; VIRAL VECTORS; GENE-THERAPY; ARCHITECTONIC PARCELLATION; NEUROFILAMENT PROTEIN; TRANSGENE EXPRESSION; NIGROSTRIATAL SYSTEM; CORTICAL-NEURONS;
D O I
10.1002/cne.23819
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study compared the expression pattern, laminar distribution, and cell specificity of several rAAV serotypes (2/1, 2/5, 2/7, 2/8, and 2/9) injected in the primary visual cortex (V1) of adult C57Bl/6J mice. In order to obtain specific expression in certain neuron subtypes, different promoter sequences were evaluated for excitatory cell specificity: a universal cytomegalovirus (CMV) promoter, and two versions of the excitatory neuron-specific Ca2+/calmodulin-dependent kinase subunit alpha (CaMKII alpha) promoter, CaMKII alpha 0.4 and CaMKII alpha 1.3. The spatial distribution as well as the cell type specificity was immunohistochemically verified. Depending on the rAAV serotype used, the transduced volume expressing reporter protein differed substantially (rAAV2/5 >> 2/7 approximate to 2/9 approximate to 2/8 >> 2/1). Excitatory neuron-specific targeting was promoter dependent, with a surprising difference between the 1.3 kb and 0.4 kb CaMKII alpha promoters. While CaMKII alpha 1.3 and CMV carrying vectors were comparable, with 78% of the transduced neurons being excitatory for CMV and 82% for CaMKII alpha 1.3, the shorter CaMKII alpha 0.4 version resulted in 95% excitatory specificity. This study therefore puts forward the CaMKII alpha 0.4 promoter as the best choice to target excitatory neurons with rAAVs. Together, these results can be used as an aid to select the most optimal vector system to deliver transgenes into specific rodent neocortical circuits, allowing further elucidation of their functions. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:2019 / 2042
页数:24
相关论文
共 50 条
  • [21] Administration of rAAV2 and rAAV5 to the Parotid Gland of Non-Human Primates
    Voutetakis, A.
    Zheng, C.
    Chiorini, J. A.
    Schmidt, M.
    Afione, S.
    Metzger, M.
    Dunbar, C.
    Donahue, R. E.
    Baum, B. J.
    MOLECULAR THERAPY, 2006, 13 : S260 - S260
  • [22] Evaluation of rAAV2/5 trans-splicing dual vector delivery in polarized human airway epithelia and mouse lung
    Yan, ZY
    Zhang, YL
    Zac, R
    Godwin, S
    Peluso, R
    Engelhardt, JF
    MOLECULAR THERAPY, 2003, 7 (05) : S41 - S41
  • [23] Production of rAAV2/HBoV1 Vector in Insect Cells
    Qiu, Jianming
    MOLECULAR THERAPY, 2020, 28 (04) : 536 - 536
  • [24] Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat
    Mariana S. Dias
    Victor G. Araujo
    Taliane Vasconcelos
    Qiuhong Li
    William W. Hauswirth
    Rafael Linden
    Hilda Petrs-Silva
    Gene Therapy, 2019, 26 : 479 - 490
  • [25] Limb Girdle Muscular Dystrophy 2I: Generation of a New Mouse Model and Test of Therapeutic Approaches by rAAV2/9 Gene Transfer
    Gicquel, Evelyne
    Charton, Karine
    Daniele, Nathalie
    Richard, Isabelle
    MOLECULAR THERAPY, 2013, 21 : S233 - S233
  • [26] Successful transgene expression despite immunization to rAAV2 upon airway administration
    Fischer, AC
    Barberena, CI
    Guggino, WB
    MOLECULAR THERAPY, 2003, 7 (05) : S184 - S184
  • [27] Comparative study of rAAV2/7 purification methods for transduction in the mouse brain following serum free production
    Toelen, Jaan
    Van der Perren, Anke
    Michiels, Martine
    Thiry, Irina
    Van Den Haute, Chris
    Gijsbers, Rik
    Baekelandt, Veerle
    Debyser, Zeger
    HUMAN GENE THERAPY, 2008, 19 (10) : 1201 - 1201
  • [28] Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina
    Hori, Tesshu
    Fukutome, Masashi
    Maejima, Chiseto
    Matsushima, Hiroki
    Kobayashi, Kensuke
    Kitazawa, Soichiro
    Kitahara, Ryo
    Kitano, Katsunori
    Kobayashi, Kenta
    Moritoh, Satoru
    Koike, Chieko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (01) : 222 - 227
  • [29] Limb Girdle Muscular Dystrophy 2I: Use of a new mouse model to test therapeutic approaches by rAAV2/9 gene transfer
    Gicquel, Evelyne
    Charton, Karine
    Daniele, Nathalie
    Richard, Isabelle
    HUMAN GENE THERAPY, 2012, 23 (05) : A3 - A4
  • [30] Limb Girdle Muscular Dystrophy 2I: Generation of a new mouse model and test of therapeutic approaches by rAAV2/9 gene transfer
    Gicquel, Evelyne
    Charton, Karine
    Daniele, Nathalie
    Richard, Isabelle
    HUMAN GENE THERAPY, 2012, 23 (10) : A131 - A131